The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Commentary: Putting this treatment within reach of all New Yorkers, regardless of their income level, will improve public ...

Leading the discussion was Dr. Shalabh Mohan, Consultant Laparoscopic and Bariatric Surgeon at RAK Hospital, who shared ...

Obesity has woven itself into the fabric of our nation, threatening the vitality of our youth, the productivity of our ...

The organization plans to back GLP-1s like Wegovy and Zepbound to treat obesity in adults as part of a shift in addressing the global obesity epidemic ... to seek out GLP-1 solutions.

UNAM's Applied Literature Seminar is blending literature and real-world transformation to tackle Mexico's biggest social ...

Estimates suggest that around four million people could benefit from weight loss injections. But only 500,000 are thought to ...

Ebn Sina Medical, a subsidiary of Aamal Company QPSC and a leading supplier of pharmaceutical, and Novo Nordisk, the Danish ...

Simultaneous liver transplant and sleeve gastrectomy (LTSG) yield durable weight loss, resolution of diabetes and ...